The Institut Valencià de Finances (IVF) has approved a subsidised financing operation benefiting Overgenes, a biotechnology company based in Valencia specialized in advanced genetic testing, gut microbiota analysis, nutrigenetics, and personalized medicine solutions.
This financing will enable the company to expand and accelerate its genetic platform, with the aim of strengthening its technological capabilities and consolidating its position in the precision and personalized healthcare sector.
In this regard, Overgenes operates its proprietary Automated Intelligence Genetics (AIG) platform, which is already fully operational and continuously evolving. The platform integrates advanced genomic analysis, proprietary algorithms for variant classification and interpretation, polygenic risk scoring, microbiome data, clinical and biochemical biomarkers, as well as explainable AI models to transform biological data into high-value personalized clinical and preventive recommendations.
The company also offers a portfolio of products and services that includes nutrigenetics solutions and other key areas of medicine, providing comprehensive responses for both healthcare professionals and end users.
The support from the IVF will allow Overgenes to continue advancing its AIG technology, enhance its genomic and clinical data analysis capabilities, and expand its product portfolio, reinforcing its position as a reference in precision health.
As highlighted by the Director General of IVF, Enrique Montes, “IVF is committed to highly innovative sectors and companies with strong growth potential such as Overgenes, which combine scientific knowledge and technological development to generate added value in the healthcare field.”
The operation is part of the IVF Pyme Investment Subsidised Financing Line, an instrument designed to offer companies optimal financial conditions to undertake strategic growth and consolidation projects.
This financing line provides long-term loans of up to 10 years, with up to 3 years of grace period, allowing companies to focus on their investments without putting pressure on their cash flow. It also offers fixed interest rate loans of 1.75%, providing financial stability and predictability.
cloud technology axon
Since its public launch in 2025, the platform has served more than 200...
